Michelle L Kelley1, Adrian J Bravo2, Victoria R Votaw2, Elena Stein3, Jason C Redman4, Katie Witkiewitz3. 1. Department of Psychology, Old Dominion University, United States; Virginia Consortium Program in Clinical Psychology, United States. Electronic address: mkelley@odu.edu. 2. Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, United States. 3. Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, United States; Department of Psychology, University of New Mexico, United States. 4. Combat Wounded Coalition, Overcome Academy, United States.
Abstract
BACKGROUND: Military veterans wounded in combat are a high-risk group for emotional and physical distress, which may be exacerbated by misuse of prescription opioids and sedatives. The goal of the current study was to examine the prevalence and correlates of prescription opioid and sedative misuse among veterans wounded in combat. METHOD: We recruited veterans from the Combat Wounded Coalition (n = 212; 84% non-Hispanic White; 97.6% male) to complete an online survey of mental health and substance use disorder symptoms, assessed via the DSM-5 Self-Rated Level 1 Cross-Cutting Symptoms Measure, the Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5, the Pain Enjoyment General Activity Scale, and the Alcohol Use Disorders Identification Test (AUDIT). Prescription opioid and sedative misuse was assessed by frequency of use in the past year that was not currently prescribed or using more than prescribed. RESULTS: Participants reported high rates of past year prescription opioid misuse (46.2%) and sedative misuse (21.7%). Misuse of both opioids and sedatives was associated with the most distress, including greater depression, anger, sleep disturbance, AUDIT scores, PTSD symptoms, suicidality, and pain interference. In multivariable multinomial logistic regression analyses, greater sleep disturbance (OR = 1.73) was associated with greater odds of sedative misuse versus no misuse. Higher AUDIT scores were associated with greater risk of sedative misuse (OR = 1.16) versus opioid misuse only. CONCLUSIONS: Military veterans wounded in combat have high rates of prescription opioid misuse and sedative misuse. Sleep problems and AUDIT scores might help identify veterans who are at most risk for opioid and sedative misuse.
BACKGROUND: Military veterans wounded in combat are a high-risk group for emotional and physical distress, which may be exacerbated by misuse of prescription opioids and sedatives. The goal of the current study was to examine the prevalence and correlates of prescription opioid and sedative misuse among veterans wounded in combat. METHOD: We recruited veterans from the Combat Wounded Coalition (n = 212; 84% non-Hispanic White; 97.6% male) to complete an online survey of mental health and substance use disorder symptoms, assessed via the DSM-5 Self-Rated Level 1 Cross-Cutting Symptoms Measure, the Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5, the Pain Enjoyment General Activity Scale, and the Alcohol Use Disorders Identification Test (AUDIT). Prescription opioid and sedative misuse was assessed by frequency of use in the past year that was not currently prescribed or using more than prescribed. RESULTS:Participants reported high rates of past year prescription opioid misuse (46.2%) and sedative misuse (21.7%). Misuse of both opioids and sedatives was associated with the most distress, including greater depression, anger, sleep disturbance, AUDIT scores, PTSD symptoms, suicidality, and pain interference. In multivariable multinomial logistic regression analyses, greater sleep disturbance (OR = 1.73) was associated with greater odds of sedative misuse versus no misuse. Higher AUDIT scores were associated with greater risk of sedative misuse (OR = 1.16) versus opioid misuse only. CONCLUSIONS: Military veterans wounded in combat have high rates of prescription opioid misuse and sedative misuse. Sleep problems and AUDIT scores might help identify veterans who are at most risk for opioid and sedative misuse.
Authors: Jayamalathi Priyanka Vakkalanka; Brian C Lund; Stephan Arndt; William Field; Mary Charlton; Marcia M Ward; Ryan M Carnahan Journal: Health Serv Res Date: 2021-12-18 Impact factor: 3.734
Authors: Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall Journal: Drug Alcohol Rev Date: 2022-04-18
Authors: Priyanka Vakkalanka; Brian C Lund; Stephan Arndt; William Field; Mary Charlton; Marcia M Ward; Ryan M Carnahan Journal: Am J Prev Med Date: 2021-05-19 Impact factor: 5.043
Authors: Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams Journal: BMC Public Health Date: 2020-11-18 Impact factor: 3.295